Millie Nelson

Editor, BioProcess Insider

Journalist covering global biopharmaceutical manufacturing and processing news and host of the Voices of Biotech podcast.

I am currently living and working in London but I grew up in Lincolnshire (UK) and studied in Newcastle (UK).

Got a story? Feel free to email me at [email protected]

Latest from Millie Nelson

Ins & Outs: Genezen new CEO to lead transition into full service CDMO
Deal-Making
Ins & Outs: Genezen new CEO to lead transition into full service CDMOIns & Outs: Genezen new CEO to lead transition into full service CDMO
byMillie Nelson
Sep 14, 2021
3 Min Read
Sandoz expands biosimilar pipeline in Bio-Thera collaboration
Deal-Making
Sandoz expands biosimilar pipeline in Bio-Thera collaborationSandoz expands biosimilar pipeline in Bio-Thera collaboration
byMillie Nelson
Sep 13, 2021
2 Min Read

All from Millie Nelson

Moderna to develop mRNA therapeutic for ultra-rare disease
Deal-Making
Moderna to develop mRNA therapeutic for ultra-rare disease
Moderna to develop mRNA therapeutic for ultra-rare disease
Sep 9, 2021
|
2 Min Read
byMillie Nelson
Sanofi bolsters stem cell biz with $1.9bn Kadmon buy
Deal-Making
Sanofi bolsters stem cell biz with $1.9bn Kadmon buy
Sanofi bolsters stem cell biz with $1.9bn Kadmon buy
Sep 9, 2021
|
2 Min Read
byMillie Nelson
BioLife bolsters CGT portfolio through Sexton acquisition
Deal-Making
BioLife bolsters CGT portfolio through Sexton acquisition
BioLife bolsters CGT portfolio through Sexton acquisition
Sep 7, 2021
|
2 Min Read
byMillie Nelson
CDMOs snapping up plants – a microtrend in the CGT space?
Facilities & Capacity
CDMOs snapping up plants – a microtrend in the CGT space?
CDMOs snapping up plants – a microtrend in the CGT space?
Sep 7, 2021
|
3 Min Read
byMillie Nelson
PE firm 3i to create injectable CDMO ten23 health
Deal-Making
PE firm 3i to create injectable CDMO ten23 health
PE firm 3i to create injectable CDMO ten23 health
Sep 6, 2021
|
2 Min Read
byMillie Nelson
Japan halts Moderna vaccine doses due to CDMO contamination fears
Facilities & Capacity
Japan halts Moderna vaccine doses due to CDMO contamination fears
Japan halts Moderna vaccine doses due to CDMO contamination fears
Sep 1, 2021
|
3 Min Read
byMillie Nelson
Biopharma playing second fiddle to chips and electronics in Samsung’s latest spending spree
Facilities & Capacity
Biopharma playing second fiddle to chips and electronics in Samsung’s latest spending spree
Biopharma playing second fiddle to chips and electronics in Samsung’s latest spending spree
Aug 27, 2021
|
3 Min Read
byMillie Nelson
Terumo and PhotonPharma partner to develop cancer vaccine
Deal-Making
Terumo and PhotonPharma partner to develop cancer vaccine
Terumo and PhotonPharma partner to develop cancer vaccine
Aug 27, 2021
|
2 Min Read
byMillie Nelson
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Deal-Making
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Sartorius and McMaster University to ‘perfect’ antibody manufacturing process
Aug 25, 2021
|
2 Min Read
byMillie Nelson
Pfizer to acquire Trillium in $2.3bn deal
Deal-Making
Pfizer to acquire Trillium in $2.3bn deal
Pfizer to acquire Trillium in $2.3bn deal
Aug 25, 2021
|
2 Min Read
byMillie Nelson
Lonza bulks up China offering with drug product plant
Facilities & Capacity
Lonza bulks up China offering with drug product plant
Lonza bulks up China offering with drug product plant
Aug 24, 2021
|
2 Min Read
byMillie Nelson
Zymeworks on how to keep immune system at bay when developing bispecifics
Upstream & Downstream Processing
Zymeworks on how to keep immune system at bay when developing bispecifics
Zymeworks on how to keep immune system at bay when developing bispecifics
Aug 23, 2021
|
5 Min Read
byMillie Nelson
Biotage triples lipid capacity to support mRNA vaccines
Facilities & Capacity
Biotage triples lipid capacity to support mRNA vaccines
Biotage triples lipid capacity to support mRNA vaccines
Aug 19, 2021
|
1 Min Read
byMillie Nelson
Polyplus reagent aims to ease CGT manufacturing issues
Upstream & Downstream Processing
Polyplus reagent aims to ease CGT manufacturing issues
Polyplus reagent aims to ease CGT manufacturing issues
Aug 18, 2021
|
2 Min Read
byMillie Nelson
Moderna inks deal to build mRNA facility in Canada
Facilities & Capacity
Moderna inks deal to build mRNA facility in Canada
Moderna inks deal to build mRNA facility in Canada
Aug 13, 2021
|
1 Min Read
byMillie Nelson
Ginkgo and Aldevron partnership delivers tenfold mRNA improvement
Facilities & Capacity
Ginkgo and Aldevron partnership delivers tenfold mRNA improvement
Ginkgo and Aldevron partnership delivers tenfold mRNA improvement
Aug 13, 2021
|
2 Min Read
byMillie Nelson
Artiva to build Californian NK cell therapy manufacturing facility
Facilities & Capacity
Artiva to build Californian NK cell therapy manufacturing facility
Artiva to build Californian NK cell therapy manufacturing facility
Aug 12, 2021
|
2 Min Read
byMillie Nelson
MaxCyte to support Sana’s ex vivo cell therapy plans
Deal-Making
MaxCyte to support Sana’s ex vivo cell therapy plans
MaxCyte to support Sana’s ex vivo cell therapy plans
Aug 12, 2021
|
2 Min Read
byMillie Nelson
BeiGene sets sights on US with NJ manufacturing facility
Facilities & Capacity
BeiGene sets sights on US with NJ manufacturing facility
BeiGene sets sights on US with NJ manufacturing facility
Aug 10, 2021
|
2 Min Read
byMillie Nelson
Appia partners with Kite to develop cell therapies for blood and bone cancers
Deal-Making
Appia partners with Kite to develop cell therapies for blood and bone cancers
Appia partners with Kite to develop cell therapies for blood and bone cancers
Aug 10, 2021
|
2 Min Read
byMillie Nelson
MilliporeSigma: 'Viral vectors will dominate the next decade’
Upstream & Downstream Processing
MilliporeSigma: 'Viral vectors will dominate the next decade’
MilliporeSigma: 'Viral vectors will dominate the next decade’
Aug 9, 2021
|
5 Min Read
byMillie Nelson
Amgen forks out $550m to build drug substance facility in NC
Facilities & Capacity
Amgen forks out $550m to build drug substance facility in NC
Amgen forks out $550m to build drug substance facility in NC
Aug 6, 2021
|
2 Min Read
byMillie Nelson
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
Deal-Making
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
Aug 5, 2021
|
2 Min Read
byMillie Nelson
Sanofi bolsters mRNA capabilities with Translate buy
Deal-Making
Sanofi bolsters mRNA capabilities with Translate buy
Sanofi bolsters mRNA capabilities with Translate buy
Aug 3, 2021
|
2 Min Read
byMillie Nelson
Ins & Outs: ‘CDMOs are now the leaders in the biomanufacturing space’
Global Markets
Ins & Outs: ‘CDMOs are now the leaders in the biomanufacturing space’
Ins & Outs: ‘CDMOs are now the leaders in the biomanufacturing space’
Aug 2, 2021
|
7 Min Read
byMillie Nelson
BioNTech to develop mRNA-based malaria vaccine
Facilities & Capacity
BioNTech to develop mRNA-based malaria vaccine
BioNTech to develop mRNA-based malaria vaccine
Aug 2, 2021
|
2 Min Read
byMillie Nelson
Resilience forks out $110m for Bluebird site in cell therapy partnership
Deal-Making
Resilience forks out $110m for Bluebird site in cell therapy partnership
Resilience forks out $110m for Bluebird site in cell therapy partnership
Jul 30, 2021
|
2 Min Read
byMillie Nelson
Catalent aims to shorten development timelines through GPEx tech launch
Facilities & Capacity
Catalent aims to shorten development timelines through GPEx tech launch
Catalent aims to shorten development timelines through GPEx tech launch
Jul 29, 2021
|
2 Min Read
byMillie Nelson
Belgian Biotechs unite to manufacture llama-based COVID antibodies
Deal-Making
Belgian Biotechs unite to manufacture llama-based COVID antibodies
Belgian Biotechs unite to manufacture llama-based COVID antibodies
Jul 28, 2021
|
2 Min Read
byMillie Nelson
Cytiva & Pall: Chromotography, cell culture and SUS to benefit from $1.5bn boost
Facilities & Capacity
Cytiva & Pall: Chromotography, cell culture and SUS to benefit from $1.5bn boost
Cytiva & Pall: Chromotography, cell culture and SUS to benefit from $1.5bn boost
Jul 27, 2021
|
2 Min Read
byMillie Nelson
Samsung Biologics to manufacture Kineta’s antibody immunotherapy
Deal-Making
Samsung Biologics to manufacture Kineta’s antibody immunotherapy
Samsung Biologics to manufacture Kineta’s antibody immunotherapy
Jul 26, 2021
|
2 Min Read
byMillie Nelson
Catalent ploughs $100m in Italian facility to up drug substance production
Facilities & Capacity
Catalent ploughs $100m in Italian facility to up drug substance production
Catalent ploughs $100m in Italian facility to up drug substance production
Jul 22, 2021
|
2 Min Read
byMillie Nelson
BioNTech adds Kite’s T cell platform and production facility
Deal-Making
BioNTech adds Kite’s T cell platform and production facility
BioNTech adds Kite’s T cell platform and production facility
Jul 21, 2021
|
2 Min Read
byMillie Nelson

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024